Our study revealed that pentamidine restores T-cell activity, enhances T-cell-mediated anti-cancer cytotoxicity, and inhibits in vivo tumor growth by interfering with the interaction between PD-1 and PD-L1. This evidence concerns the gene CD274 and neoplasm.